Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)

By  

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6630-6642

Bentham Science Publishers

Access to resources Recommend Favorite

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art

By Muller R.H.   Mader K.   Gohla S.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 161-177

Elsevier

Access to resources Recommend Favorite

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

By Muchow Marc   Maincent Philippe   Muller Rainer  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 12, 2008-12 ,pp. : 1394-1405

Informa Healthcare

Access to resources Recommend Favorite

Correlation between long-term stability of solid lipid nanoparticles (SLN&unknown;) and crystallinity of the lipid phase

By Freitas C.   Muller R.H.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 47, Iss. 2, 1999-03 ,pp. : 125-132

Elsevier

Access to resources Recommend Favorite

Editorial: Applications of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): State of the Art

By  

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6551-6552

Bentham Science Publishers

Access to resources Recommend Favorite